PPA1
Inorganic pyrophosphatase
Also known as: IOPPP, IPYR_HUMAN, PP, PP1, Ppase, SID6-8061
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q15181
- Gene
- PPA1
- Ensembl
- ENSG00000180817
- Chromosome
- 10
- Canonical length
- 289 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Vesicles
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene is a member of the inorganic pyrophosphatase (PPase) family. PPases catalyze the hydrolysis of pyrophosphate to inorganic phosphate, which is important for the phosphate metabolism of cells. Studies of a similar protein in bovine suggested a cytoplasmic localization of this enzyme. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
289 residues, UniProt reviewed canonical sequence.
>Q15181|PPA1
1 MSGFSTEERA APFSLEYRVF LKNEKGQYIS PFHDIPIYAD KDVFHMVVEV PRWSNAKMEI
61 ATKDPLNPIK QDVKKGKLRY VANLFPYKGY IWNYGAIPQT WEDPGHNDKH TGCCGDNDPI
121 DVCEIGSKVC ARGEIIGVKV LGILAMIDEG ETDWKVIAIN VDDPDAANYN DINDVKRLKP
181 GYLEATVDWF RRYKVPDGKP ENEFAFNAEF KDKDFAIDII KSTHDHWKAL VTKKTNGKGI
241 SCMNTTLSES PFKCDPDAAR AIVDALPPPC ESACTVPTDV DKWFHHQKNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PPA1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 308 nTPM
Expression across tissuesHPA
Tissue
- retina: 308 nTPM
- spinal cord: 228 nTPM
- cerebellum: 194 nTPM
- adrenal gland: 182 nTPM
- pancreas: 178 nTPM
- midbrain: 177 nTPM
Single-cell type
- esophageal apical cells: 1,223 nCPM
- müller glia: 951 nCPM
- gastric progenitor cells: 931 nCPM
- esophageal basal cells: 833 nCPM
- esophageal suprabasal cells: 776 nCPM
- endometrial luminal cells: 646 nCPM
Immune cell
- myeloid DC: 190 nTPM
- MAIT T-cell: 131 nTPM
- naive CD4 T-cell: 123 nTPM
- T-reg: 121 nTPM
- memory CD4 T-cell: 113 nTPM
- naive CD8 T-cell: 107 nTPM
Brain region
- cerebellum: 167 nTPM
- white matter: 163 nTPM
- pons: 163 nTPM
- spinal cord: 152 nTPM
- medulla oblongata: 142 nTPM
- hypothalamus: 129 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.84
- DepMap mean gene effect
- -0.89
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PPA1 as an antibody target. Whether an autoantibody or antibody against PPA1 could matter depends on whether native PPA1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PPA1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PPA1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...